Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Unilever eyes GSK's consumer goods arm in possible 50 bln-pound deal

Sat, 15th Jan 2022 11:03

* Unilever confirms interest in GSK assets

* GSK consumer business would be "strong strategic fit"

* Sunday Times says 50 billion-pound bid rejected in late
2021

* Unilever is under pressure from shareholders over stock
price
(Adds Unilever comment, details on performance, investor
activism)

By Siddharth Cavale, Ludwig Burger and Mrinmay Dey

Jan 15 (Reuters) - Consumer goods giant Unilever
said it had approached Glaxosmithkline about buying the
pharmaceutical group's consumer goods arm, after a newspaper
reported that a 50 billion-pound ($68.4 billion) bid it made had
been rebuffed.

Unilever, which has been under fire from some investors over
its underperforming share price, confirmed the approach about a
potential acquisition of the business in a statement on
Saturday.

"GSK Consumer Healthcare is a leader in the attractive
consumer health space and would be a strong strategic fit as
Unilever continues to re-shape its portfolio," it said.

"There can be no certainty that any agreement will be
reached."

GSK declined to comment on the approach. The group's
consumer goods business is due to be spun out into a separate
listing in the middle of this year.

Earlier, Britain's Sunday Times said the Unilever bid for
the business made late last year was worth roughly 50 billion
pounds, and had been rejected as too low by GSK and Pfizer
, which owns a minority stake in the division.

The approach by Unilever, which owns brands such as Dove
soap and Marmite, for Glaxo’s portfolio of household brands
including Panadol painkillers and Sensodyne toothpaste was
understood to have been unsolicited, the report added.

The bid did not include any takeover premium or recognition
of synergies, the newspaper said, adding that it was not clear
whether the group would make a higher offer.

Unilever declined to comment on whether it would return with
a higher bid. Brokerage Jefferies last year put a valuation for
the whole consumer unit at 45 billion pounds.

The offer comes at a time Unilever's Chief Executive Alan
Jope is under pressure to turn around its languishing stock
price as it struggles to compete in the face of high
inflationary costs, especially in emerging markets, its biggest
source of revenue.

The FTSE-listed conglomerate's stock has fallen 10% over the
past year compared with P&G's 18% rise and Reckitt's 1.4%
decline, despite a pandemic-driven boost in shopping for
groceries and household goods that has benefited all three
companies.

British fund manager Terry Smith, whose Fundsmith vehicle is
a top-10 Unilever investor, this week criticized the group for
promoting sustainability credentials at the expense of
performance.

Smith was not immediately available to comment.

INVESTOR PRESSURE

Investor activism has also reared its head at GSK.

In April last year, U.S. activist hedge fund Elliott
Management revealed a multi-billion pound stake in GSK, putting
pressure on CEO Emma Walmsley to explore a shake-up of the
company after it fell behind in the COVID-19 vaccine race.

The consumer remedies industry, which has traditionally been
attached to the prescription drug sector, is also in a phase of
major transformation as several pharma companies no longer see a
benefit in a combination.

Johnson & Johnson in November unveiled plans to spin
off its consumer health division, owner of the Listerine and
Baby Powder brands, to focus on pharmaceuticals and medical
devices. Sanofi has said its consumer unit would become
“standalone” business.

For Unilever, the deal would be the biggest move for Jope
since becoming CEO in 2019.

He has previously shot down suggestions that Unilever was in
the market for big deals, saying instead that the company would
focus on smaller acquisitions in fast-growing areas such as
luxury beauty, plant-based foods and health and wellness.

If a deal with GSK does go through, it will be Unilever's
second with the company after it bought its health food drinks
business, including Horlicks, in India and other Asian markets
for 3.3 billion euros in 2018.

($1 = 0.7314 pounds)

(Writing by William Schomberg; Editing by Mark Heinrich and Jan
Harvey)

More News
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.